Global Nifedipine Controlled-release Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

October 2026 | 91 pages | ID: G28D3D3EEF0DEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Nifedipine Controlled-release Tablets market size was valued at US$ 990 million in 2025 and is forecast to a readjusted size of US$ 1143 million by 2032 with a CAGR of 2.1% during review period.

Nifedipine Controlled-release Tablets, also known as Nifedipine Gastrointestinal Therapeutic System (GITS), are an advanced extended-release antihypertensive formulation commonly available in 30mg per tablet. The system is based on an osmotic pump design, comprising a drug-containing layer and an osmotically active push layer, all enclosed in a semi-permeable membrane and protective coating. After ingestion, the push layer absorbs gastrointestinal fluid and swells, gradually forcing the drug through a precision laser-drilled orifice. This enables a slow and sustained release of the active ingredient, helping maintain stable blood drug levels for effective management of hypertension or angina, while reducing dosing frequency and improving patient compliance.

Nifedipine controlled-release tablets have been widely used for the treatment of hypertension and angina for many years in both domestic and international markets. Compared to conventional tablets, their sustained-release mechanism helps minimize blood pressure fluctuations, reduce side effects, and improve patient adherence, making them particularly suitable for long-term management of moderate to severe hypertension. In China, the market is dominated by generics, with some formulations adopting advanced imported technologies like the GITS osmotic pump system, ensuring stable efficacy and pharmacokinetics. These formulations are well covered by medical insurance and are commonly prescribed across tertiary hospitals and primary healthcare settings.With the continued rise in hypertension prevalence and an aging population, alongside growing awareness of chronic disease management, demand for safe, long-acting, and patient-friendly antihypertensive drugs will remain strong. Nifedipine controlled-release tablets are well positioned to benefit from this trend. As centralized procurement policies expand and generic consistency evaluations become standard, manufacturers with advanced formulation technologies are expected to stand out. Future product development will likely focus on diversified specifications and dosage forms to meet personalized treatment needs. Innovations in delivery platforms—such as updated osmotic systems, microneedles, or mucoadhesive formulations—are also being explored to enhance controlled-release performance and market differentiation.Key drivers include a strong balance between efficacy and safety, endorsement in clinical guidelines, wide insurance coverage, and alignment with chronic disease care models. These tablets significantly improve adherence in long-term therapy and play an important role in grassroots hypertension control programs. However, challenges exist: proprietary controlled-release technologies such as GITS present high entry barriers, and some generics struggle to fully replicate the reference release profile. Meanwhile, aggressive price cuts under centralized procurement have compressed profit margins, increasing pressure on small- to mid-sized manufacturers. Additionally, competition from newer calcium channel blockers and combination therapies poses a risk of substitution in certain clinical application.

This report is a detailed and comprehensive analysis for global Nifedipine Controlled-release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

  • Global Nifedipine Controlled-release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
  • Global Nifedipine Controlled-release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
  • Global Nifedipine Controlled-release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2021-2032
  • Global Nifedipine Controlled-release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Nifedipine Controlled-release Tablets
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Nifedipine Controlled-release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Shanghai Shyndec Pharmaceutical, Beijing Honglin Pharma, Nanjing Easeheal Pharmaceutical, Qingdao BAHEAL Pharmaceutical, Simcere Pharmaceutical, Hefei Lifeon Pharmaceutical, China Resources Double-Crane Pharmaceutical, CSPC Ouyi Pharmaceutical, ApicHope Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Nifedipine Controlled-release Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Generic Drug
  • Original Drug

Market segment by Application

  • Hypertension
  • Coronary Heart Disease
  • Chronic Stable Angina
  • Other

Major players covered

  • Bayer
  • Shanghai Shyndec Pharmaceutical
  • Beijing Honglin Pharma
  • Nanjing Easeheal Pharmaceutical
  • Qingdao BAHEAL Pharmaceutical
  • Simcere Pharmaceutical
  • Hefei Lifeon Pharmaceutical
  • China Resources Double-Crane Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • ApicHope Pharmaceutical

Market segment by region, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

  • Chapter 1, to describe Nifedipine Controlled-release Tablets product scope, market overview, market estimation caveats and base year.
  • Chapter 2, to profile the top manufacturers of Nifedipine Controlled-release Tablets, with price, sales quantity, revenue, and global market share of Nifedipine Controlled-release Tablets from 2021 to 2026.
  • Chapter 3, the Nifedipine Controlled-release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
  • Chapter 4, the Nifedipine Controlled-release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
  • Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
  • Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nifedipine Controlled-release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
  • Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
  • Chapter 13, the key raw materials and key suppliers, and industry chain of Nifedipine Controlled-release Tablets.
  • Chapter 14 and 15, to describe Nifedipine Controlled-release Tablets sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Nifedipine Controlled-release Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Generic Drug
  1.3.3 Original Drug
1.4 Market Analysis by Application
  1.4.1 Overview: Global Nifedipine Controlled-release Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.4.2 Hypertension
  1.4.3 Coronary Heart Disease
  1.4.4 Chronic Stable Angina
  1.4.5 Other
1.5 Global Nifedipine Controlled-release Tablets Market Size & Forecast
  1.5.1 Global Nifedipine Controlled-release Tablets Consumption Value (2021 & 2025 & 2032)
  1.5.2 Global Nifedipine Controlled-release Tablets Sales Quantity (2021-2032)
  1.5.3 Global Nifedipine Controlled-release Tablets Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Bayer
  2.1.1 Bayer Details
  2.1.2 Bayer Major Business
  2.1.3 Bayer Nifedipine Controlled-release Tablets Product and Services
  2.1.4 Bayer Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Bayer Recent Developments/Updates
2.2 Shanghai Shyndec Pharmaceutical
  2.2.1 Shanghai Shyndec Pharmaceutical Details
  2.2.2 Shanghai Shyndec Pharmaceutical Major Business
  2.2.3 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.2.4 Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
2.3 Beijing Honglin Pharma
  2.3.1 Beijing Honglin Pharma Details
  2.3.2 Beijing Honglin Pharma Major Business
  2.3.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product and Services
  2.3.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Beijing Honglin Pharma Recent Developments/Updates
2.4 Nanjing Easeheal Pharmaceutical
  2.4.1 Nanjing Easeheal Pharmaceutical Details
  2.4.2 Nanjing Easeheal Pharmaceutical Major Business
  2.4.3 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.4.4 Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Nanjing Easeheal Pharmaceutical Recent Developments/Updates
2.5 Qingdao BAHEAL Pharmaceutical
  2.5.1 Qingdao BAHEAL Pharmaceutical Details
  2.5.2 Qingdao BAHEAL Pharmaceutical Major Business
  2.5.3 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.5.4 Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
2.6 Simcere Pharmaceutical
  2.6.1 Simcere Pharmaceutical Details
  2.6.2 Simcere Pharmaceutical Major Business
  2.6.3 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.6.4 Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Simcere Pharmaceutical Recent Developments/Updates
2.7 Hefei Lifeon Pharmaceutical
  2.7.1 Hefei Lifeon Pharmaceutical Details
  2.7.2 Hefei Lifeon Pharmaceutical Major Business
  2.7.3 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.7.4 Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Hefei Lifeon Pharmaceutical Recent Developments/Updates
2.8 China Resources Double-Crane Pharmaceutical
  2.8.1 China Resources Double-Crane Pharmaceutical Details
  2.8.2 China Resources Double-Crane Pharmaceutical Major Business
  2.8.3 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.8.4 China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 China Resources Double-Crane Pharmaceutical Recent Developments/Updates
2.9 CSPC Ouyi Pharmaceutical
  2.9.1 CSPC Ouyi Pharmaceutical Details
  2.9.2 CSPC Ouyi Pharmaceutical Major Business
  2.9.3 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.9.4 CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
2.10 ApicHope Pharmaceutical
  2.10.1 ApicHope Pharmaceutical Details
  2.10.2 ApicHope Pharmaceutical Major Business
  2.10.3 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
  2.10.4 ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 ApicHope Pharmaceutical Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: NIFEDIPINE CONTROLLED-RELEASE TABLETS BY MANUFACTURER

3.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2021-2026)
3.2 Global Nifedipine Controlled-release Tablets Revenue by Manufacturer (2021-2026)
3.3 Global Nifedipine Controlled-release Tablets Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Nifedipine Controlled-release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Nifedipine Controlled-release Tablets Manufacturer Market Share in 2025
  3.4.3 Top 6 Nifedipine Controlled-release Tablets Manufacturer Market Share in 2025
3.5 Nifedipine Controlled-release Tablets Market: Overall Company Footprint Analysis
  3.5.1 Nifedipine Controlled-release Tablets Market: Region Footprint
  3.5.2 Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
  3.5.3 Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Nifedipine Controlled-release Tablets Market Size by Region
  4.1.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2021-2032)
  4.1.2 Global Nifedipine Controlled-release Tablets Consumption Value by Region (2021-2032)
  4.1.3 Global Nifedipine Controlled-release Tablets Average Price by Region (2021-2032)
4.2 North America Nifedipine Controlled-release Tablets Consumption Value (2021-2032)
4.3 Europe Nifedipine Controlled-release Tablets Consumption Value (2021-2032)
4.4 Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value (2021-2032)
4.5 South America Nifedipine Controlled-release Tablets Consumption Value (2021-2032)
4.6 Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
5.2 Global Nifedipine Controlled-release Tablets Consumption Value by Type (2021-2032)
5.3 Global Nifedipine Controlled-release Tablets Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
6.2 Global Nifedipine Controlled-release Tablets Consumption Value by Application (2021-2032)
6.3 Global Nifedipine Controlled-release Tablets Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
7.2 North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
7.3 North America Nifedipine Controlled-release Tablets Market Size by Country
  7.3.1 North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2032)
  7.3.2 North America Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
8.2 Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
8.3 Europe Nifedipine Controlled-release Tablets Market Size by Country
  8.3.1 Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2032)
  8.3.2 Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Nifedipine Controlled-release Tablets Market Size by Region
  9.3.1 Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
10.2 South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
10.3 South America Nifedipine Controlled-release Tablets Market Size by Country
  10.3.1 South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2032)
  10.3.2 South America Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Nifedipine Controlled-release Tablets Market Size by Country
  11.3.1 Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Nifedipine Controlled-release Tablets Market Drivers
12.2 Nifedipine Controlled-release Tablets Market Restraints
12.3 Nifedipine Controlled-release Tablets Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Nifedipine Controlled-release Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Nifedipine Controlled-release Tablets
13.3 Nifedipine Controlled-release Tablets Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Nifedipine Controlled-release Tablets Typical Distributors
14.3 Nifedipine Controlled-release Tablets Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES

Table 1. Global Nifedipine Controlled-release Tablets Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Nifedipine Controlled-release Tablets Product and Services
Table 6. Bayer Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Bayer Recent Developments/Updates
Table 8. Shanghai Shyndec Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Shanghai Shyndec Pharmaceutical Major Business
Table 10. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 11. Shanghai Shyndec Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 13. Beijing Honglin Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Honglin Pharma Major Business
Table 15. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product and Services
Table 16. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Beijing Honglin Pharma Recent Developments/Updates
Table 18. Nanjing Easeheal Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Nanjing Easeheal Pharmaceutical Major Business
Table 20. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 21. Nanjing Easeheal Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Nanjing Easeheal Pharmaceutical Recent Developments/Updates
Table 23. Qingdao BAHEAL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qingdao BAHEAL Pharmaceutical Major Business
Table 25. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 26. Qingdao BAHEAL Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Qingdao BAHEAL Pharmaceutical Recent Developments/Updates
Table 28. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Simcere Pharmaceutical Major Business
Table 30. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 31. Simcere Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Simcere Pharmaceutical Recent Developments/Updates
Table 33. Hefei Lifeon Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Hefei Lifeon Pharmaceutical Major Business
Table 35. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 36. Hefei Lifeon Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Hefei Lifeon Pharmaceutical Recent Developments/Updates
Table 38. China Resources Double-Crane Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. China Resources Double-Crane Pharmaceutical Major Business
Table 40. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 41. China Resources Double-Crane Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. China Resources Double-Crane Pharmaceutical Recent Developments/Updates
Table 43. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. CSPC Ouyi Pharmaceutical Major Business
Table 45. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 46. CSPC Ouyi Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 48. ApicHope Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. ApicHope Pharmaceutical Major Business
Table 50. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Product and Services
Table 51. ApicHope Pharmaceutical Nifedipine Controlled-release Tablets Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. ApicHope Pharmaceutical Recent Developments/Updates
Table 53. Global Nifedipine Controlled-release Tablets Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 54. Global Nifedipine Controlled-release Tablets Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global Nifedipine Controlled-release Tablets Average Price by Manufacturer (2021-2026) & (US$/g)
Table 56. Market Position of Manufacturers in Nifedipine Controlled-release Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and Nifedipine Controlled-release Tablets Production Site of Key Manufacturer
Table 58. Nifedipine Controlled-release Tablets Market: Company Product Type Footprint
Table 59. Nifedipine Controlled-release Tablets Market: Company Product Application Footprint
Table 60. Nifedipine Controlled-release Tablets New Market Entrants and Barriers to Market Entry
Table 61. Nifedipine Controlled-release Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2021-2026) & (kg)
Table 64. Global Nifedipine Controlled-release Tablets Sales Quantity by Region (2027-2032) & (kg)
Table 65. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global Nifedipine Controlled-release Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global Nifedipine Controlled-release Tablets Average Price by Region (2021-2026) & (US$/g)
Table 68. Global Nifedipine Controlled-release Tablets Average Price by Region (2027-2032) & (US$/g)
Table 69. Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 70. Global Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 71. Global Nifedipine Controlled-release Tablets Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global Nifedipine Controlled-release Tablets Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global Nifedipine Controlled-release Tablets Average Price by Type (2021-2026) & (US$/g)
Table 74. Global Nifedipine Controlled-release Tablets Average Price by Type (2027-2032) & (US$/g)
Table 75. Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 76. Global Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 77. Global Nifedipine Controlled-release Tablets Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global Nifedipine Controlled-release Tablets Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global Nifedipine Controlled-release Tablets Average Price by Application (2021-2026) & (US$/g)
Table 80. Global Nifedipine Controlled-release Tablets Average Price by Application (2027-2032) & (US$/g)
Table 81. North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 82. North America Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 83. North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 84. North America Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 85. North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2026) & (kg)
Table 86. North America Nifedipine Controlled-release Tablets Sales Quantity by Country (2027-2032) & (kg)
Table 87. North America Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America Nifedipine Controlled-release Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 90. Europe Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 91. Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 92. Europe Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 93. Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2026) & (kg)
Table 94. Europe Nifedipine Controlled-release Tablets Sales Quantity by Country (2027-2032) & (kg)
Table 95. Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe Nifedipine Controlled-release Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 98. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 99. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 100. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 101. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2021-2026) & (kg)
Table 102. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity by Region (2027-2032) & (kg)
Table 103. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 106. South America Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 107. South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 108. South America Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 109. South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2026) & (kg)
Table 110. South America Nifedipine Controlled-release Tablets Sales Quantity by Country (2027-2032) & (kg)
Table 111. South America Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America Nifedipine Controlled-release Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2021-2026) & (kg)
Table 114. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Type (2027-2032) & (kg)
Table 115. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2021-2026) & (kg)
Table 116. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Application (2027-2032) & (kg)
Table 117. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2021-2026) & (kg)
Table 118. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity by Country (2027-2032) & (kg)
Table 119. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Nifedipine Controlled-release Tablets Raw Material
Table 122. Key Manufacturers of Nifedipine Controlled-release Tablets Raw Materials
Table 123. Nifedipine Controlled-release Tablets Typical Distributors
Table 124. Nifedipine Controlled-release Tablets Typical Customers

LIST OF FIGURES

Figure 1. Nifedipine Controlled-release Tablets Picture
Figure 2. Global Nifedipine Controlled-release Tablets Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Nifedipine Controlled-release Tablets Revenue Market Share by Type in 2025
Figure 4. Generic Drug Examples
Figure 5. Original Drug Examples
Figure 6. Global Nifedipine Controlled-release Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application in 2025
Figure 8. Hypertension Examples
Figure 9. Coronary Heart Disease Examples
Figure 10. Chronic Stable Angina Examples
Figure 11. Other Examples
Figure 12. Global Nifedipine Controlled-release Tablets Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global Nifedipine Controlled-release Tablets Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global Nifedipine Controlled-release Tablets Sales Quantity (2021-2032) & (kg)
Figure 15. Global Nifedipine Controlled-release Tablets Price (2021-2032) & (US$/g)
Figure 16. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of Nifedipine Controlled-release Tablets by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 Nifedipine Controlled-release Tablets Manufacturer (Revenue) Market Share in 2025
Figure 21. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2021-2032)
Figure 23. North America Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 26. South America Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 28. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global Nifedipine Controlled-release Tablets Consumption Value Market Share by Type (2021-2032)
Figure 30. Global Nifedipine Controlled-release Tablets Average Price by Type (2021-2032) & (US$/g)
Figure 31. Global Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 32. Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032)
Figure 33. Global Nifedipine Controlled-release Tablets Average Price by Application (2021-2032) & (US$/g)
Figure 34. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 36. North America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2021-2032)
Figure 38. United States Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 43. Europe Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 46. France Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 52. Asia-Pacific Nifedipine Controlled-release Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific Nifedipine Controlled-release Tablets Consumption Value Market Share by Region (2021-2032)
Figure 54. China Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 57. India Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 60. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 62. South America Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 68. Middle East & Africa Nifedipine Controlled-release Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa Nifedipine Controlled-release Tablets Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa Nifedipine Controlled-release Tablets Consumption Value (2021-2032) & (USD Million)
Figure 74. Nifedipine Controlled-release Tablets Market Drivers
Figure 75. Nifedipine Controlled-release Tablets Market Restraints
Figure 76. Nifedipine Controlled-release Tablets Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Nifedipine Controlled-release Tablets in 2025
Figure 79. Manufacturing Process Analysis of Nifedipine Controlled-release Tablets
Figure 80. Nifedipine Controlled-release Tablets Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source